These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 22120832)
1. The insulin sensitizing effects of PPAR-γ agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats. Pita J; Panadero A; Soriano-Guillén L; Rodríguez E; Rovira A Regul Pept; 2012 Feb; 174(1-3):18-25. PubMed ID: 22120832 [TBL] [Abstract][Full Text] [Related]
2. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs. Shen X; Li H; Li W; Wu X; Ding X Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128 [TBL] [Abstract][Full Text] [Related]
4. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle. Li W; Tonelli J; Kishore P; Owen R; Goodman E; Scherer PE; Hawkins M Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1301-7. PubMed ID: 17213476 [TBL] [Abstract][Full Text] [Related]
5. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin. Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836 [TBL] [Abstract][Full Text] [Related]
6. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats. Qi Z; Xue J; Zhang Y; Wang H; Xie M Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873 [TBL] [Abstract][Full Text] [Related]
7. Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Beylot M; Pinteur C; Peroni O Metabolism; 2006 Mar; 55(3):396-401. PubMed ID: 16483885 [TBL] [Abstract][Full Text] [Related]
8. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat. Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648 [TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498 [TBL] [Abstract][Full Text] [Related]
10. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299 [TBL] [Abstract][Full Text] [Related]
11. The effect of renal transplantation on adiponectin and its isoforms and receptors. Shen YY; Charlesworth JA; Kelly JJ; Peake PW Metabolism; 2007 Sep; 56(9):1201-8. PubMed ID: 17697862 [TBL] [Abstract][Full Text] [Related]
12. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats. Laurent D; Gounarides JS; Gao J; Boettcher BR Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377 [TBL] [Abstract][Full Text] [Related]
13. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469 [TBL] [Abstract][Full Text] [Related]
14. A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy. Blümer RM; van der Valk M; Ackermans M; Endert E; Serlie MJ; Reiss P; Sauerwein HP Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1097-104. PubMed ID: 19690066 [TBL] [Abstract][Full Text] [Related]
15. Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes. Kudoh A; Satoh H; Hirai H; Watanabe T Life Sci; 2011 Jun; 88(23-24):1055-62. PubMed ID: 21514306 [TBL] [Abstract][Full Text] [Related]
16. Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome. Glintborg D; Frystyk J; Højlund K; Andersen KK; Henriksen JE; Hermann AP; Hagen C; Flyvbjerg A; Andersen M Clin Endocrinol (Oxf); 2008 Feb; 68(2):165-74. PubMed ID: 17803698 [TBL] [Abstract][Full Text] [Related]
17. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776 [TBL] [Abstract][Full Text] [Related]
18. PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Ye JM; Iglesias MA; Watson DG; Ellis B; Wood L; Jensen PB; Sørensen RV; Larsen PJ; Cooney GJ; Wassermann K; Kraegen EW Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E531-40. PubMed ID: 12556350 [TBL] [Abstract][Full Text] [Related]
19. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533 [TBL] [Abstract][Full Text] [Related]
20. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats. Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]